TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
MANE

Veradermics, Incorporated

Healthcare · Biotechnology

117.80$ +0.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Veradermics, Incorporated (MANE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 153 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MANE
Line item 2023 2024 2025
18 59 153
18 56 152
16 53 22
16 53 142
– 1.4 1.3
3.8 4.7 274
3.1 4.7 9.2
1.9 2.2 2.1
0.8 – –
15 55 -121
-23 -49 -123
201 201 35

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?